ZCM
BVS icon

Zebra Capital Management’s Bioventus BVS Stock Holding History

Zebra Capital Management’s Portfolio BVS Stock Details BVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-30,038
Closed -$210K – 69
2022
Q3 		$210K Buy
30,038
+12,469
+71% +$97.6K 0.8% 52
2022
Q2 		$120K Sell
17,569
-426
-2% -$4.35K 0.35% 85
2022
Q1 		$254K Buy
+17,995
New +$241K 0.58% 70

Other funds holding BVS

EWM
Essex Woodlands Management The Woodlands, Texas $254M AUM 4.59% 1-Year Est. Return
JIC
Juniper Investment Company New York $378M AUM 95.37% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
KLC
Kent Lake Capital Reno, Nevada $222M AUM 18.04% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
JFG
Jefferies Financial Group New York $15.2B AUM 55.75% 1-Year Est. Return

Zebra Capital Management's BVS Position: Q4 2022 in Review

Zebra Capital Management sold out of Bioventus (BVS) in Q4 2022, closing a stake of 30,038 shares — an estimated $210K sold.

Zebra Capital Management first reported a position in BVS in Q1 2022 and held it in 3 quarters. The position peaked at $254K in Q1 2022. 84 funds tracked by Wall St. Rank hold BVS as of Q4 2022.

  • Zebra Capital Management reported no remaining Bioventus position as of Q4 2022 after selling out during the quarter.
  • Zebra Capital Management sold 30,038 Bioventus shares in Q4 2022, an estimated $210K.
  • Zebra Capital Management first reported a position in Bioventus in Q1 2022 and held it in 3 quarters.
  • Zebra Capital Management's Bioventus position peaked at $254K in Q1 2022.
  • 84 funds tracked by Wall St. Rank held Bioventus as of Q4 2022.

Based on Zebra Capital Management's 13F filing for Q4 2022, filed 14 Feb 2023.